HOME >> BIOLOGY >> NEWS
Incubator company at NJIT develops lifesaving MRI coil for small animals

NEWARK, Mar 7-Supertron, a start-up technology company housed in the small business incubators at New Jersey Institute of Technology (NJIT, announced today that it has begun developing a cryogenic coil to improve Magnetic Resonance Imaging (MRI) scanners.

"The new coil will be well suited for animal imaging," said Supertron President Jon T. DeVries. "Small animal models, particularly genetically engineered mice, are becoming an increasingly powerful tool for cancer researchers. This potential has not been fully realized to date due to the need to sacrifice the animal and conduct tissue and molecular analysis thereby losing out on the opportunity to observe, in vivo, the evolution of the processes under study."

The New Jersey Economic Development Authority (NJEDA) recently awarded the company a $250,000 Springboard II grant. This money follows an earlier $2 million grant in 2003 from the National Institute of Science and Technology (NIST) at the US Department of Commerce.

Erzhen Gao, PhD, director of research and development for the company will lead the effort. The tests will be conducted through a series of animal studies conducted at University of Medicine and Dentistry of New Jersey (UMDNJ).

"Eventually, we hope to see our system upgrade existing MRI scanners because our coils can enhance installed MRIs, enabling them to produce cleaner, clearer and easier-to-read images at an affordable price," said DeVries. A medical school is testing another Supertron coil system developed for low field MRIs of the human head.

DeVries said interest in small animal imaging is growing and cited programs doing this research including the Small Animal Imaging Resource Program at the National Cancer Institute.

Coils are the receiving antenna of the radio waves emitted during an MRI scan and are essential to the MRI's operation. An MRI clinic may have as many as ten coils, each designed for specific anatomical parts (spine, he
'"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
7-Mar-2005


Page: 1 2 3

Related biology news :

1. Colorado company to sell medical food products based on Wake Forest discovery
2. Spin-out company seeks medicines from South American rain forests
3. New company will seek drugs against diabetes and cancer
4. EMBL scientists found start-up company to develop anti-cancer drugs
5. New waste water technology company wins 2006 EUREKA Lynx Award
6. Yale technology spins out varicose vein device company: Vascular Insights, LLC
7. Innovative technology for production of new pharmaceuticals forms basis of new company
8. Ossur acquires US orthotics company Royce Medical
9. USF spin-out company Saneron CCEL wins federal award for cell therapy
10. Idaho lab, Utah company achieve major milestone in hydrogen research
11. N.C. A&T food scientist develops process for allergen-free peanuts

Post Your Comments:
(Date:12/17/2014)... DENVER , Dec. 16, 2014  Automation ... is this more evident than at international borders. ... secure document scanners have allowed veteran travelers to ... Automated Passport Control (APC) Kiosks at an increasing ... the globe. According to ...
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays a ... while. Hypertension – the medical term for high blood pressure ... 1800s, and the inflatable cuff that,s used in measuring blood ... mean there,s nothing new about hypertension, its triggers and its ... about the condition and the best ways to treat it. ...
(Date:12/10/2014)... 9, 2014  Wake Forest Baptist Medical Center today announced ... School of Medicine. Funding for this $50 million capital ... will be publicly launched next summer. ... former 60 series R.J. Reynolds Tobacco Company complex, adjacent ... begin immediately with plans to be ready to welcome ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
(Date:12/17/2014)... USA (PRWEB) December 16, 2014 ... manager at Philipps- Universität Marburg’s Department of Physics, ... photonics, in the newly released SPIE Women ... never be too shy to ask questions.” , ... technology, engineering, and mathematics) occupations ranging from university ...
(Date:12/17/2014)... N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today announced ... (referred to as Somatuline®) was approved by the ... treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult ... advanced or metastatic disease to improve progression-free survival ...
(Date:12/17/2014)... 17, 2014 This report is ... Tubing industry. For an overview analysis, the report ... industry chain structure, industry overview, policy analysis, and ... industry has witnessed rapid development with key ... acquisitions. This report mentions quartz tubing upstream raw ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
Breaking Biology Technology:Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 82020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2
Cached News: